TB should be diagnosed before using a fluoroquinolone [5]

British Medical Journal

Volumn 327, Issue 7407, 2003, Pages 164-165

  Agarwal, Atul ^a  

^a Maharaja Agrasen Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; EARLY DIAGNOSIS; HUMAN; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0038037380     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Rodger A, Jaffar S, Paynter S, Hayward A, Carless J, Maguire H. Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data. BMJ 2003;326:909-10.
2. Agarwal A, Agarwal V. Inadvertent use of ciprofloxacin as a single drug in undiagnosed tuberculosis. J Assoc Physicians Inda 1997;45:747.